Martin Shkreli to go toe-to-toe with new FTC chair over Daraprim price spikes

Much ink has been spilled over “Pharma Bro” Martin Shkreli, the entrepreneur who raised the price of a lifesaving antiparasitic more than 55-fold overnight and is currently serving a seven-year prison sentence for securities fraud.